Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea
- PMID: 24503544
- PMCID: PMC3913554
- DOI: 10.1371/journal.pmed.1001598
Molecular diagnostics for gonorrhoea: implications for antimicrobial resistance and the threat of untreatable gonorrhoea
Abstract
This Essay from Nicola Low and colleagues discusses the importance of the nucleic acid amplification tests for rapid detection of N. gonorrhoeae and its resistance determinants, as well as the importance of ensuring their rational use, as priorities for controlling both gonorrhoea and antimicrobial resistance.
Please see later in the article for the Editors' Summary
Conflict of interest statement
NL is a member of the Editorial Board of
Figures
References
-
- Davies SC, Fowler T, Watson J, Livermore DM, Walker D (2013) Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistance. Lancet 381: 1606–1609. - PubMed
-
- World Health Organization (2012) Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: World Health Organization.
-
- Ison CA, Town K, Obi C, Chisholm S, Hughes G, et al. (2013) Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007–2011. Lancet Infect Dis 13: 762–768. - PubMed
-
- Tapsall JW, Ndowa F, Lewis DA, Unemo M (2009) Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae . Expert Rev Anti Infect Ther 7: 821–834. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
